Brinton, US
Chris Brinton, Leesburg, VA US
Patent application number | Description | Published |
---|---|---|
20100100257 | Visual airport surface and terminal area data system - The invention supports the study of operations and provides a large data store of surface and terminal area operations, as well as means of analyzing and understanding that data. It fuses multiple surveillance and flight data sources to provide analysis functionality for both airborne and surface based flights. This provides a wider range of data to make intelligent categorization and derived data analysis decisions. The invention implements custom logic for matching flights to corresponding data messages by maintaining its own key mappings between data tables during import so that keys are unique to an installation and do not require sequences. This provides the ability to export datasets through the PostgreSQL dump utility and then import it into an existing database (using the PostgreSQL restore utility) without creating overlapping, duplicate or conflicting keys. XML based format is used and import and export features is that allow users to share these custom queries. | 04-22-2010 |
Christopher G. Brinton, Berkeley Heights, NJ US
Patent application number | Description | Published |
---|---|---|
20140120516 | Methods and Systems for Creating, Delivering, Using, and Leveraging Integrated Teaching and Learning - The present invention is directed to methods and systems that redefine how a course is taught and how material is learned in a large-scale class environment. In this system, there is adaptation of content presentation for each student, based on the tracking, learning, and profiling of student learning efficiency. Furthermore, the textbook of the present invention can be created during the delivery of course content, and sold at a variety of granularity. | 05-01-2014 |
Christopher Greg Brinton, Berkeley Heights, NJ US
Patent application number | Description | Published |
---|---|---|
20160049083 | SYSTEMS AND METHODS FOR AUTHORING AN INTEGRATED AND INDIVIDUALIZED COURSE OR TEXTBOOK - The present invention is directed towards methods and systems to assist an author in constructing an electronic course or textbook (referred to generally as a course). The system allows an author to integrate various types of content into his/her course, and to specify a set of rules that will determine if and how the content will be individualized to each end user; the resultant courses are thus termed Integrated and Individualized Courses (IIC). Through the system, an author is able to import content files into an authoring application, and then use this application to edit the files, arrange them into segments, and define the course structure as a sequence of these segments, all through drag and drop functionality. | 02-18-2016 |
20160063881 | SYSTEMS AND METHODS TO ASSIST AN INSTRUCTOR OF A COURSE - A system and method to assist an instructor in managing, understanding, and drawing conclusions about the learning behavior. The system includes methods for processing data collected about users as they interact with the various modalities of learning that may be integrated into the course, and rendering this information into visualizations that are displayed on an instructor dashboard and updated in real time. This instructor interface includes a plurality of modules targeted towards the management of and interaction with users, and the analysis and visualization of a different aspect of their learning | 03-03-2016 |
20160104261 | SYSTEMS AND METHODS FOR INTEGRATING AN E-LEARNING COURSE DELIVERY PLATFORM WITH AN ENTERPRISE SOCIAL NETWORK - The present invention is directed towards systems and methods for integrating electronic learning (eLearning) platforms with Enterprise Social Networks (ESNs) in corporate learning settings. | 04-14-2016 |
Danica Milosevic Brinton, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20130144596 | LOCALIZATION FRAMEWORK FOR DYNAMIC TEXT - An apparatus and method providing a localization framework capable of localizing dynamic text is disclosed herein. The localization framework is configured to automatically identify and prioritize certain text contained within an application code base to be translated. Such text is pre-processed prior to translation to facilitate accurate and complete translation in a target language. | 06-06-2013 |
20160103826 | LOCALIZATION FRAMEWORK FOR DYNAMIC TEXT - An apparatus and method providing a localization framework capable of localizing dynamic text is disclosed herein. The localization framework is configured to automatically identify and prioritize certain text contained within an application code base to be translated. Such text is pre-processed prior to translation to facilitate accurate and complete translation in a target language. | 04-14-2016 |
Derrick J. Brinton, Lafayette, CA US
Patent application number | Description | Published |
---|---|---|
20140205973 | Interactive genealogical charts - Presenting genealogical information. A method includes displaying a representation of a first individual. The method further includes displaying a ring chart for the first individual. The ring chart includes elements representing individuals with familial relationships to the first individual in a ring chart fashion. Displaying a ring chart includes displaying the ring chart with visual coding. The visual coding indicates a level of completeness of research done for individuals represented in the ring chart. | 07-24-2014 |
James Eric Brinton, Greenwood, SC US
Patent application number | Description | Published |
---|---|---|
20080207108 | Roof Light System Having a Ventilation Device with Improved Flexibility - The roof light system is composed by a roof unit ( | 08-28-2008 |
20100011682 | SEAMLESS DECK-SEALING SURROUND FOR SKYLIGHTS AND ROOF WINDOWS - A seamless surround for a rectangular skylight assembly is provided. Each side of the rectangular surround is characterized as having an obtuse-angled profile having an angle of between greater than 90 degrees and about 100 degrees, the profile including a vertically extending surface and a downwardly sloping surface. The vertically extending surfaces abut curb members attached to the skylight assembly and include apertures therethrough for receipt of a joining element. The downwardly sloping surfaces abut a building rooftop and further include apertures therethrough for receipt of a joining element. The roof-abutting side of the downwardly sloping surfaces includes a barrier material attached thereto. The barrier material may be any suitable air and water barrier, such as a polyurethane foam or a thermoplastic elastomer. A method of installing a skylight having the seamless surround is also provided. | 01-21-2010 |
20100018138 | VENTILATED CURB-MOUNT SKYLIGHT WITH SEPARABLE HINGE - Provided herein is a curb-mounted skylight having a rigid plastic curb frame, a mechanism for firmly securing the curb frame to an opening in a building, a transparent or translucent covering element, and a mechanism for retaining the covering element on the frame. The curb frame includes a fixed base frame (having an interior frame and a counter-flashing element) and a moveable sash frame (having an accessory shelf and a sash). The base frame and the sash frame may be connected to one another by a first hinge member integral with the counter-flashing element and a cooperative and complementary-shaped second hinge member attached to the sash. The hinge members form a watertight seal and may be disengaged to permit the sash to be removed from the skylight assembly during installation, if so desired. Because the frame and hinge components are made of plastic, the skylight assembly is relatively lightweight. | 01-28-2010 |
20120011787 | DECK-SEALING SURROUND FOR SKYLIGHTS AND WINDOWS - A surround for a rectangular skylight assembly is provided. Each side of the rectangular surround is characterized as having an obtuse-angled profile having an angle of between greater than 90 degrees and about 100 degrees, the profile including a curb-abutting surface and a roof abutting surface. The curb-abutting surfaces abut curb members attached to the skylight assembly and include apertures therethrough for receipt of joining elements. The roof abutting surfaces abut a building rooftop and further include apertures therethrough for receipt of joining elements. The roof abutting side of the roof abutting surfaces includes a barrier material attached thereto. The barrier material may be comprised of any suitable impermeable material, such as a polyurethane foam or a thermoplastic elastomer. | 01-19-2012 |
Joel D. Brinton, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20140249695 | LOW LATENCY DATA LINK SYSTEM AND METHOD - Devices and methods for a low latency data telecommunication system and method for video, audio control data and other data for use with one or more robots and remote controls are disclosed. The data transmission can be digital. The data telecommunication system can enable the use of multiple robots and multiple remote controls in the same location with encrypted data transmission. | 09-04-2014 |
Joel Daniel Brinton, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20160044503 | Protecting Radio Transmitter Identity - A system and a method are disclosed for protecting the privacy of a wireless data transmission. A request is received from a client device to connect to a base station. A session identification is assigned to the client device and a set of transmission identifications are generated using a block cipher with the assigned session identification and a secret key as input. The transmission identifications identify a frequency channel and a time slot for the client device to wirelessly transmit a message to the base station. The set of transmission identifications are then encrypted and sent to the client device. | 02-11-2016 |
20160044682 | Radio Transmitter Identification and Congestion Control - A system and a method are disclosed for transmitting and receiving wireless signals in a shared communication channel. Embodiments include sending, by a client device, a request to connect with a base station and receiving, in response to the request, a message including a radio transmission slot and a digital identifier. The radio transmission slot identifies a frequency channel and a time slot for transmitting a wireless signal. The client device can then transmit wireless signals using the frequency channel identified by the radio transmission slot during the time slot identified by the radio transmission slot. The client device encodes the digital identifier in the transmitted wireless signal. | 02-11-2016 |
Keith A. Brinton, Henderson, NV US
Patent application number | Description | Published |
---|---|---|
20140327251 | DOOR LATCH SECURITY DEVICES AND RELATED METHODS - Door latch security devices for maintaining doors closed may comprise latch engagement arms configured to obstruct a swinging arm of a door latch from disengaging from a fixed bar of the door latch. A support member may be connected to the latch engagement arms. The support member may be configured to contact the swinging arm of a door latch to support the door latch security device on the door latch. A channel may be defined between the latch engagement arms. The channel may be sized to at least partially receive a swinging arm and a fixed bar of a door latch within the channel. | 11-06-2014 |
Margo A. Brinton, Decatur, GA US
Patent application number | Description | Published |
---|---|---|
20090186842 | Methods and compositions for inhibition of viral replication - The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to methods and compositions comprising RNA sequences to which the host cell proteins TIAR and/or TIA-1 bind. | 07-23-2009 |
20100166704 | Methods and compositions for inhibition of viral replication - The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to inhibition of flavivirus replication wherein the replication is affected by changing the normal interactions of the host cell protein TIAR or TIA-1. | 07-01-2010 |
Marshall K. Brinton, Spicer, MN US
Patent application number | Description | Published |
---|---|---|
20080279863 | THERAPEUTIC ANTIBODIES FOR TREATMENT AND PROPHYLAXIS OF TRANSMITTABLE VIRAL DISEASES - The invention provides methods and compositions for the treatment and prevention of a transmittable disease in a subject, such as avians and mammals. The methods and compositions of the invention specifically make use of avian antibodies to the disease to be treated or prevented. Administration of such avian antibodies to a subject has been shown effective for reducing mortality in a population of subjects that are infected, or become infected, with the disease. The invention also provides kits useful for detecting the presence of transmittable diseases in subjects. | 11-13-2008 |
20110150904 | Therapeutic Antibodies for Treatment and Prophylaxis of Transmittable Viral Diseases - The invention provides methods and compositions for the treatment and prevention of a transmittable disease in a subject, such as avians and mammals. The methods and compositions of the invention specifically make use of avian antibodies to the disease to be treated or prevented. Administration of such avian antibodies to a subject has been shown effective for reducing mortality in a population of subjects that are infected, or become infected, with the disease. The invention also provides kits useful for detecting the presence of transmittable diseases in subjects. | 06-23-2011 |
Michael D. Brinton, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090189791 | FONT OR KEYSTROKE BIOMETRICS - Systems are provided that include an input device with a plurality of keys, at least one of the plurality of keys including a biometric sensor disposed therein. The system generally executes an application, receives input from a plurality of users using the input device, determines the identity of the user submitting the input, and attributes actual contribution in the application to the identified user. | 07-30-2009 |
Michael D. Brinton, Washington, D.c. US
Patent application number | Description | Published |
---|---|---|
20140223278 | VIEWING FILE MODIFICATIONS - Upon closing and/or saving a file, a user may view changes made to the file. | 08-07-2014 |
Michael D. Brinton, White Plains, NY US
Patent application number | Description | Published |
---|---|---|
20090307579 | VIEWING FILE MODIFICATIONS - Upon closing and/or saving a file, a user may view changes made to the file. | 12-10-2009 |
Roberta Brinton, Rancho Palos Verdes, CA US
Patent application number | Description | Published |
---|---|---|
20120231052 | NEUROPROTECTION AND MYELIN REPAIR USING NESTORONE.RTM. - Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration. | 09-13-2012 |
20130116217 | NEUROPROTECTION AND MYELIN REPAIR USING NESTORONE.RTM. - Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration, and include effects on stroke and TBI. | 05-09-2013 |
Roberta Diaz Brinton, Rancho Palos Verdes, CA US
Patent application number | Description | Published |
---|---|---|
20080200441 | ESTROGEN RECEPTOR MODULATORS ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE - Selective estrogen receptor modulators, as well their related pharmaceutical compositions and methods of use, are provided herein. These estrogen receptor modulators include compounds that primarily exhibit estrogen receptor antagonist activity or primarily exhibit selective estrogen receptor antagonist and agonist activity, i.e., SERM activity, in specific tissue types. Particular embodiments provide compounds that behave as NeuroSERMs promoting neurotrophism and neuroprotection in brain tissue. These NeuroSERMs represent a subset of the modulators compounds provided herein that can cross the blood-brain-barrier and exert estrogen receptor agonist-like effects in the brain. The compounds should be useful for treating a variety of diseases, particularly estrogen receptor-mediated diseases and disorders, such as osteoporosis, breast and endometrial cancers, atherosclerosis and Alzheimer's disease. | 08-21-2008 |
20100105646 | ALLOPREGNANOLONE IN A METHOD FOR ENHANCING NEUROLOGICAL FUNCTION (ALZHEIMER DISEASE) - Neuro-enhancing agents, compositions and methods are disclosed herein. Preferred neuro-enhancing agents of the present invention include progesterone and metabolites of progesterone, such as 3α-hydroxy-5α-pregnan-20-one (THP). These agents yield neuro-enhancing effects on neural cells that include neural progenitor and/or stem cells, whereby the agents stimulate mitosis of neural progenitor cells, stimulate neurite growth and organization, protect against neural loss, or one or more of these neural processes. Thus, the neuro-enhancing agents, compositions and methods disclosed herein are useful to reverse or prevent neurological disease or defects associated with neural loss or degeneration, such as Alzheimer's disease, neurological injuries, including injuries resulting from radiation therapy, and age-related neurological decline, including impairments in memory and learning. | 04-29-2010 |
20100113586 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF MENOPAUSAL SYMPTOMS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with pre menopause, menopause, and/or post menopause are described herein. These select phytoestrogen formulations are composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in the brain. These ERβ-selective phytoestrogen formulations cross the blood-brain-barrier and promote estrogen-associated neurotrophism and neuroprotection mechanisms in the brain, without activating proliferative mechanisms in the reproductive tissues and are therefore devoid of other estrogen-associated problematic aspects. The formulations can be administered enterally, transdermally, transmucosally, intranasally or parenterally. The formulations preferably contain combinations of compounds, and can be formulated for daily, sustained, delayed or weekly/monthly administration. In a preferred embodiment, these are administered to women who are in menopause or post menopausal, most preferably early in menopausal. | 05-06-2010 |
20100204192 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCING NEUROLOGICAL FUNCTION - Neuro-enhancing agents, compositions and methods are disclosed herein. Preferred neuro-enhancing agents of the present invention include progesterone and metabolites of progesterone, such as 3α-hydroxy-5α-pregnan-20-one (THP). These agents yield neuro-enhancing effects on neural cells that include neural progenitor and/or stem cells, whereby the agents stimulate mitosis of neural progenitor cells, stimulate neurite growth and organization, protect against neural loss, or one or more of these neural processes. Thus, the neuro-enhancing agents, compositions and methods disclosed herein are useful to reverse or prevent neurological disease or defects associated with neural loss or degeneration, such as Alzheimer's disease, neurological injuries, including injuries resulting from radiation therapy, and age-related neurological decline, including impairments in memory and learning. | 08-12-2010 |
20110091435 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer/prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain. | 04-21-2011 |
20120164122 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF NEURODEGENERATIVE DISEASES - Select phytoestrogen pharmaceutical compositions and methods of use for promoting neurological heath and prevention of age-related neurodegeneration, such as AD, have been developed. These select phytoestrogen formulations are composed of a number of plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in the brain. These ERβ-selective phytoestrogen formulations cross the blood-brain-barrier and promote estrogen-associated neurotrophism and neuroprotections mechanisms in the brain, without activating proliferative mechanisms in the reproductive tissues and are therefore devoid of other estrogen-associated problematic aspects. These are administered enterally, transdermally, transmucosally, intranasally or parenterally, in a dosage effective to prevent or alleviate neuronal damage, effect neuronal regeneration or sustain viability, increase expression of anti-apoptotic proteins, and/or decrease indicators of Alzheimer's Disease. | 06-28-2012 |
20120238511 | 2-DEOXY-D-GLUCOSE FORMULATIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES - Pharmaceutical compositions containing 2-deoxy-D-glucose (2-DG) and methods of use for promoting neurological health and prevention of age-related neurodegeneration, such as Alzheimer's disease (AD), have been developed. The compositions may be formulated such that the composition, or the compound when release from the composition, crosses the blood-brain-barrier and promote neurotrophism and neuroprotection mechanisms in the brain. 2-DG can be administered alone or in combination with one or more additional therapeutic, diagnostic, and/or prophylactic agents. The compositions described herein can be administered orally, enterally, transdermally, transmucosally, intranasally or parenterally, in a dosage effective to prevent or alleviate neuronal damage, effect neuronal regeneration or sustain viability, increase expression of anti-apoptotic proteins, and/or decrease indicators of Alzheimer's Disease. The formulations can be formulated for daily, sustained, delayed or weekly/monthly administration. | 09-20-2012 |
20120269793 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer/prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain. | 10-25-2012 |
Todd Jeffrey Brinton, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20100112081 | USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES - Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically. In some embodiments, the PRP composition may be coated on one or more medical devices. The PRP composition may be delivered to an identified portion of the electrical conduction system of the heart affected and/or causing the arrhythmia to occur. | 05-06-2010 |
20150037431 | USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES - Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically. | 02-05-2015 |